References
- World Health Organization. Nutritional anaemias: tools for effective prevention and control. Geneva: World Health Organization; 2017.
- Buratti P, Gammella E, Rybinska I, Cairo G, Recalcati S. Recent advances in iron metabolism: relevance for health, exercise, and performance. Med Sci Sports Exerc. 2015;47:1596–604.
- Krishnamoorthy PM, Natesh Prabhu R, Mohan DM, Sabitha N, Janakarajan VN, Natesan B. Role of oxidative stress and antioxidants in children with IDA. Int J Collab Res Intern Med Pub Health. 2010;2: 2–18.
- Akarsu S, Demir H, Selek S, Oguzoncul F. Iron deficiency anemia and levels of oxidative stress induced by treatment modality. Pediatr Int. 2013;55:289–95. doi:10.1111/ped.12054.
- Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84. doi:10.1016/j.biocel.2006.07.001.
- Imam MU, Zhang S, Ma J, Wang H, Wang F. Antioxidants mediate both iron homeostasis and oxidative stress. Nutrients 2017;9:671. doi:10.3390/nu9070671.
- Aşkar TK, Büyükleblebici O, Hismioğulları AA, Hünkerler Z. Oxidative stress, hepcidin and nesfatin-I status in childhood iron and vitamin B12 deficiency anemias. Adv Clin Exp Med. 2017;26:621–25. doi:10.17219/acem/62829.
- Coghetto Baccin A, Lauerman Lazzaretti L, Duarte Martins Brandao V, Manfredini V, Peralba MC, Silveira Benfato M. Oxidative stress in older patients with iron deficiency anaemia. J Nutr Health Aging 2009;13:666–70. doi:10.1007/s12603-009-0195-6.
- Erenler AK, Yardan T. Clinical utility of thiol/disulfide homeostasis. Clin Lab. 2017;63:867–70. doi:10.7754/Clin.Lab.2017.161117.
- Mertoğlu C, Gunay M, Siranli G, Kulhan M, Gok G, Erel Ö. The effect of the 50 g glucose challenge test on the thiol/disulfide homeostasis in pregnancy. Fetal Pediatr Pathol. 2018;37:147–156. doi:10.1080/15513815.2018.1453002.
- Topal I, Mertoglu C, Surucu Kara I, Siranli G, Gok G, Erel Ö. Thiol-disulfide homeostasis, serum ferroxidase activity, and serum ischemia modified albumin levels in neonatal jaundice. Fetal Pediatr Pathol. 2019;11:1–8. doi:10.1080/15513815.2018.1561772.
- Ayton S, Lei P, Duce JA, Wong BXW, Sedjahtera A, Adlard PA, Bush AI, Finkelstein DI. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol. 2013;73:554–59. doi:10.1002/ana.23817.
- Sbarouni E, Georgiadou P, Kremastinos DT, Voudris V. Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol. 2008;49:260–266.
- Ncogo P, Herrador Z, Romay-Barja M, García-Carrasco E, Nseng G, Berzosa P, Santana-Morales MA, Riloha M, Aparicio P, Valladares B, et al. Malaria prevalence in Bata district, Equatorial Guinea: a cross-sectional study. Malar J. 2015;14:1–10.
- Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47:326–32. doi:10.1016/j.clinbiochem.2014.09.026.
- Erel O. Automated measurement of serum ferroxidase activity. Clin Chem. 1998;44:2313–19.
- Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000;19:311–15.
- Altun D, Kurekci AE, Gursel O, Ovunc Hacıhamdioglu D, Kurt I, Aydın A, Ozcan O. Malondialdehyde, antioxidant enzymes, and renal tubular functions in children with iron deficiency or iron-deficiency anemia. Biol Trace Elem Res. 2014;161:48–56. doi:10.1007/s12011-014-0084-7.
- Aycicek A, Koc A, Oymak Y, Selek S, Kaya C, Guzel B. Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia. J Pediatr Hematol Oncol. 2014;36:57–61. doi:10.1097/MPH.0b013e318299c91a.
- Akça H, Polat A, Koca C. Determination of total oxidative stress and total antioxidant capacity before and after the treatment of iron-deficiency anemia. J Clin Lab Anal. 2013;27:227–230. doi:10.1002/jcla.21589.
- Qian ZM, Ke Y. Rethinking the role of ceruloplasmin in brain iron metabolism. Brain Res Rev. 2011;35:287–294.
- Cichota LC, Moresco RN, Duarte MM, da Silva JE. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal. 2008;22:1–5. doi:10.1002/jcla.20226.
- Awadallah, S, Atoum M, Nimer NA, Saleh S. Ischemia modified albumin: an oxidative stress marker in β-thalassemia major. Clin Chim Acta. 2012;413:907–10. doi:10.1016/j.cca.2012.01.037.
- Bilgili S, Bozkaya G, Kırtay Tütüncüler F, Akşit M, Yavuz M. Investigation of ischemia modified albumin levels in iron deficiency anemia. Turk J Biochem. 2017;42:259–64.